Malmö University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Malmo Sweden (1998)

Organization Overview

First Clinical Trial
1998
NCT00764010
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Faculty of Odontology, Malmö University | Liselott Lindh, Principal Investigator, Prosthetic Dentistry, Malmö University, Malmö, Sweden | Malmö University | Ultrasound Laboratory at Malmoe University Hospital, Sweden

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 2)

Alcoholism (Phase 2)

Atherosclerosis (Phase 3)

Lichen Planus (Phase 3)

Lichen Planus, Oral (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 19